Copyright
©2013 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Dec 7, 2013; 19(45): 8357-8365
Published online Dec 7, 2013. doi: 10.3748/wjg.v19.i45.8357
Published online Dec 7, 2013. doi: 10.3748/wjg.v19.i45.8357
Added value of hepatobiliary phase gadoxetic acid-enhanced MRI for diagnosing hepatocellular carcinoma in high-risk patients
Sith Phongkitkarun, Kuruwin Limsamutpetch, Penampai Tannaphai, Janjira Jatchavala, Department of Diagnostic and Therapeutic Radiology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Ratchatewi, Bangkok 10400, Thailand
Author contributions: Phongkitkarun S and Limsamutpetch K contributed to the study design, statistical analyses and wrote the first draft; Phongkitkarun S, Limsamutpetch K and Tannaphai P contributed to the data acquisition; Phongkitkarun S and Jatchavala J revised the manuscript.
Correspondence to: Sith Phongkitkarun, MD, Department of Diagnostic and Therapeutic Radiology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, 270 Rama VI Road, Ratchatewi, Bangkok 10400, Thailand. sith.bkk@gmail.com
Telephone: +66-81-7542780 Fax: +66-2-2011274
Received: May 21, 2013
Revised: August 6, 2013
Accepted: September 16, 2013
Published online: December 7, 2013
Processing time: 211 Days and 10.4 Hours
Revised: August 6, 2013
Accepted: September 16, 2013
Published online: December 7, 2013
Processing time: 211 Days and 10.4 Hours
Core Tip
Core tip: This study demonstrated the added value of hepatobiliary phase gadoxetic acid-enhanced magnetic resonance imaging (MRI) for diagnosing hepatocellular carcinoma, based on the changes in contrast uptake on hepatobiliary phase images during hepatocarcinogenesis. The pitfalls of interpreting hepatobiliary phase MRI are important to recognize in obtaining the most accurate results.